tiprankstipranks
Advertisement
Advertisement

ARGX Stock Latest News

Argenx Targets Graves’ Disease With New Phase 3 Trial, Expanding Its Autoimmune Footprint
Company AnnouncementsArgenx Targets Graves’ Disease With New Phase 3 Trial, Expanding Its Autoimmune Footprint
3d ago
ARGX
Argenx Targets Graves’ Disease With New Phase 3 Trial: What Investors Should Know
PremiumCompany Announcements
Argenx Targets Graves’ Disease With New Phase 3 Trial: What Investors Should Know
3d ago
ARGX
Argenx price target raised to $945 from $890 at RBC Capital
PremiumThe Fly
Argenx price target raised to $945 from $890 at RBC Capital
4d ago
ARGX
Argenx price target raised to EUR 900 from EUR 750 at Deutsche Bank
PremiumThe Fly
Argenx price target raised to EUR 900 from EUR 750 at Deutsche Bank
8d ago
ARGX
Argenx price target raised to $1,088 from $1,016 at BofA
PremiumThe Fly
Argenx price target raised to $1,088 from $1,016 at BofA
9d ago
ARGX
Vyvgart’s INM Breakthrough and Multi‑Billion Sales Potential Drive Tazeen Ahmad’s Buy Rating on argenx and Price Target Increase to $1,088
PremiumRatingsVyvgart’s INM Breakthrough and Multi‑Billion Sales Potential Drive Tazeen Ahmad’s Buy Rating on argenx and Price Target Increase to $1,088
9d ago
ARGX
Argenx added to Q3 Tactical Ideas List at Wells Fargo
Premium
The Fly
Argenx added to Q3 Tactical Ideas List at Wells Fargo
10d ago
ARGX
Argenx Buy Rating Reiterated as Analyst Sees Undervalued Vyvgart Myositis Opportunity; $940 Price Target Maintained
Premium
Ratings
Argenx Buy Rating Reiterated as Analyst Sees Undervalued Vyvgart Myositis Opportunity; $940 Price Target Maintained
16d ago
ARGX
Argenx price target raised to $1,180 from $1,170 at Morgan Stanley
PremiumThe Fly
Argenx price target raised to $1,180 from $1,170 at Morgan Stanley
17d ago
ARGX
Argenx Showcases Autoimmune Myositis R&D in June 23 FcRn Webinar
PremiumCompany Announcements
Argenx Showcases Autoimmune Myositis R&D in June 23 FcRn Webinar
18d ago
6K
ARGX
Douglas Tsao Reiterates Buy on argenx, Keeps $940 Price Target on Durable Vyvgart Data and Upcoming Phase 3 Catalysts
PremiumRatings
Douglas Tsao Reiterates Buy on argenx, Keeps $940 Price Target on Durable Vyvgart Data and Upcoming Phase 3 Catalysts
1M ago
ARGX
Argenx Showcases Durable VYVGART Benefits in Myositis and Sjogren’s at EULAR 2026
PremiumCompany Announcements
Argenx Showcases Durable VYVGART Benefits in Myositis and Sjogren’s at EULAR 2026
1M ago
6K
ARGX
Argenx presents new Vyvgart data at EULAR
PremiumThe FlyArgenx presents new Vyvgart data at EULAR
1M ago
ARGX
Argenx price target raised to $1,291 from $1,260 at Wells Fargo
Premium
The Fly
Argenx price target raised to $1,291 from $1,260 at Wells Fargo
1M ago
ARGX
Argenx price target raised to $1,255 from $1,222 at Stifel
Premium
The Fly
Argenx price target raised to $1,255 from $1,222 at Stifel
1M ago
ARGX
Argenx price target raised to $1,059 from $1,007 at Evercore ISI
PremiumThe Fly
Argenx price target raised to $1,059 from $1,007 at Evercore ISI
2M ago
ARGX
Argenx price target raised to $1,016 from $1,013 at BofA
PremiumThe Fly
Argenx price target raised to $1,016 from $1,013 at BofA
2M ago
ARGX
Myles Minter Reiterates Buy as Vyvgart’s Expanded FDA Label and Attractive Valuation Support Continued Growth
PremiumRatings
Myles Minter Reiterates Buy as Vyvgart’s Expanded FDA Label and Attractive Valuation Support Continued Growth
2M ago
ARGX
Argenx: FDA approves label expansion for Vyvgart, Vvygart Hytrulo
PremiumThe Fly
Argenx: FDA approves label expansion for Vyvgart, Vvygart Hytrulo
2M ago
ARGX
Argenx price target lowered to $1,170 from $1,230 at Morgan Stanley
PremiumThe FlyArgenx price target lowered to $1,170 from $1,230 at Morgan Stanley
2M ago
ARGX
Argenx price target raised to $1,135 from $1,120 at Guggenheim
Premium
The Fly
Argenx price target raised to $1,135 from $1,120 at Guggenheim
2M ago
ARGX
Argenx price target raised to $1,260 from $1,247 at Wells Fargo
Premium
The Fly
Argenx price target raised to $1,260 from $1,247 at Wells Fargo
2M ago
ARGX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >